Compile Data Set for Download or QSAR

Found 1 hit Enz. Inhib. hit(s) with Target = 'fMet-Leu-Phe receptor' and Ligand = 'BDBM497404'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM497404 (US11008301, Example 56) Show SMILES OCC1CCCN(C1)c1ccc(cn1)N1CCC[C@@H](NC(=O)Nc2ccc(cc2)C(F)(F)F)C1=O |r| Show InChI InChI=1S/C24H28F3N5O3/c25-24(26,27)17-5-7-18(8-6-17)29-23(35)30-20-4-2-12-32(22(20)34)19-9-10-21(28-13-19)31-11-1-3-16(14-31)15-33/h5-10,13,16,20,33H,1-4,11-12,14-15H2,(H2,29,30,35)/t16?,20-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	45	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US11008301 (2021) BindingDB Entry DOI: 10.7270/Q2HX1GTH
					More data for this Ligand-Target Pair